Patient-tailored antithrombotic therapy following percutaneous coronary intervention

N.M.R. van der Sangen, R. Rozemeijer, DRPPCP Yin, M. Valgimigli, S. Windecker, S.K. James, S. Buccheri, J.M. ten Berg, J.P.S. Henriques, M. Voskuil, W.J. Kikkert*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1038–1046
Number of pages13
JournalEuropean Heart Journal
Volume42
Issue number10
DOIs
Publication statusPublished - 7 Mar 2021

Keywords

  • Dual antiplatelet therapy
  • Patient-tailored antithrombotic therapy
  • Risk stratification
  • DUAL-ANTIPLATELET THERAPY
  • ELUTING STENT IMPLANTATION
  • GUIDELINE FOCUSED UPDATE
  • PRECISE-DAPT SCORE
  • BARE-METAL STENTS
  • CARDIOVASCULAR EVENTS
  • OPEN-LABEL
  • MYOCARDIAL-INFARCTION
  • BIODEGRADABLE POLYMER
  • CYP2C19 GENOTYPE

Cite this